Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Expression and regulation of human endogenous retrovirus W elements.
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Falls and physical activity in persons with multiple sclerosis.
Comparison of MERGE and Axial T2-Weighted Fast Spin-Echo Sequences for Detection of Multiple Sclerosis Lesions in the Cervical Spinal Cord.
Determinants of central nervous system adult neurogenesis are sex, hormones, mouse strain, age, and brain region.
Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis.
Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients.
Sleep and oligodendrocyte functions.
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned.
Month of birth as a risk factor for multiple sclerosis: an update.
Incidence of multiple sclerosis in multiple racial and ethnic groups.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.
PERK Dependent Activation of JAK1 and STAT3 Contributes to ER Stress Induced Inflammation.
Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
"Disease modifying nutricals" for multiple sclerosis.
Fingolimod Therapy and Macular Hemorrhage.
Speech and pause characteristics in multiple sclerosis: A preliminary study of speakers with high and low neuropsychological test performance.

Pages